USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$13.68
52 Week High
$4.19
52 Week Low
NONE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$112K |
| Total Revenue | $4.4M |
| Cost Of Revenue | $4.5M |
| Costof Goods And Services Sold | $4.5M |
| Operating Income | -$14M |
| Selling General And Administrative | $10M |
| Research And Development | $3.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$3.1M |
| Interest Income | $0 |
| Interest Expense | $3.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $543K |
| Income Before Tax | -$21M |
| Income Tax Expense | -$15K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$21M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$18M |
| Ebitda | -$17M |
| Net Income | -$21M |
| Field | Value (USD) |
|---|---|
| Total Assets | $12M |
| Total Current Assets | $9.8M |
| Cash And Cash Equivalents At Carrying Value | $96K |
| Cash And Short Term Investments | $96K |
| Inventory | $8.1M |
| Current Net Receivables | $625K |
| Total Non Current Assets | $2.3M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $596K |
| Intangible Assets Excluding Goodwill | $596K |
| Goodwill | $615K |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $955K |
| Other Non Current Assets | - |
| Total Liabilities | $36M |
| Total Current Liabilities | $35M |
| Current Accounts Payable | $5.3M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $20M |
| Total Non Current Liabilities | $517K |
| Capital Lease Obligations | $951K |
| Long Term Debt | - |
| Current Long Term Debt | $20M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $21M |
| Other Current Liabilities | $9.6M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | -$24M |
| Treasury Stock | - |
| Retained Earnings | -$50M |
| Common Stock | $1K |
| Common Stock Shares Outstanding | $72M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$12M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $543K |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | -$1.3M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | $12M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$21M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$112K |
| Total Revenue | $4.4M |
| Cost Of Revenue | $4.5M |
| Costof Goods And Services Sold | $4.5M |
| Operating Income | -$14M |
| Selling General And Administrative | $10M |
| Research And Development | $3.4M |
| Operating Expenses | $14M |
| Investment Income Net | - |
| Net Interest Income | -$3.1M |
| Interest Income | $0 |
| Interest Expense | $3.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $543K |
| Income Before Tax | -$21M |
| Income Tax Expense | -$15K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$21M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$18M |
| Ebitda | -$17M |
| Net Income | -$21M |
Sector: NONE
Industry: NONE
Picard Medical, Inc. is a leading innovator in the medical device industry, specializing in the design, manufacturing, and marketing of advanced medical products. The company is committed to enhancing patient care through cutting-edge technology and high-quality offerings that cater to a wide range of healthcare needs. With a robust portfolio of products, Picard Medical aims to transform medical procedures and improve clinical outcomes, positioning itself as a key player in the evolving healthcare landscape. Through strategic partnerships and a focus on research and development, Picard Medical continues to push the boundaries of medical technology to deliver superior solutions to healthcare providers.